Contact:

Office of Communications (pr@colby.edu)
207-859-4350

On Monday, April 8, at Colby College David Shlaes, vice president of infectious disease research at Wyeth Pharmaceuticals, will present a lecture titled “The National Response to Bioterrorism.” The 8 p.m. event will be held in room 01 of the F.W. Olin Science Center on the Waterville campus and is open to the public free of charge. A reception will follow.

As vice president for infectious disease research at Wyeth Pharmaceuticals, a global leader in research-based pharmaceutical products, Shlaes works on discovering and developing anti-bacterial and anti-viral compounds. During last fall’s anthrax scare Shlaes testified before Congress on the industry’s poor state of preparedness for bioterrorism.

Shlaes has also worked as chief of infectious diseases at VA Medical Center in Cleveland, Ohio, and as a professor of medicine at Case Western Reserve University. He is a member of the Institute of Medicine’s Forum on Emerging Infections and participates in Institute activities related to bioterrorism. Shlaes earned both a Ph.D. in microbiology and a medical degree from Case Western Reserve.

This event is sponsored by Colby’s Herbert Carlyle Libby Lecture Fund, the Cultural Events Committee and the History and Biology departments.